Results 201 to 210 of about 239,330 (291)

Evidence-Based Management of MASLD: GRADE Evaluation of Pharmacological Therapies. [PDF]

Pharmaceuticals (Basel)
Karavia EA, Pittaras A, Andreopoulou O, Hatziri A, Makrydimitri A, Anagnostopoulos D, Vareltzis P, Kypreos KE.   +7 more
europepmc   +1 more source

Ten‐year follow‐up of bilateral gingival recession treatment: A case report

Clinical Advances in Periodontics, EarlyView.
Abstract Background This work aims to present a 10‐year follow‐up of a young patient who underwent treatment with collagen matrix (CM) combined with enamel matrix derivative (EMD) for bilateral gingival recessions in the maxillary canine region. Methods The patient, a 25‐year‐old woman, presented with bilateral Cairo type 1 recessions.
Luiz C. L. Marques‐Junior, Milena S. Irie, Edgar Daniel Vargas‐Quiroga, Mario Taba‐Jr, Atila V. V. Nobre   +4 more
wiley   +1 more source

Effect of Simulated Oral Aging on Surface Roughness and Microhardness of Bulk-Fill Composite Resins. [PDF]

Dent J (Basel)
Tănasă AM, Tărăboanță I, Nica I, Tărăboanță-Gamen AC, Tofan N, Brânzan RC, Brânză-Concită CA, Andrian S.   +7 more
europepmc   +1 more source

Consumer Mobile Phone Recycling Behaviour: A Systematic Review and Future Research Agenda

Journal of Consumer Behaviour, EarlyView.
ABSTRACT Mobile phone recycling has received increasing attention from scholars and practitioners due to its environmental, social, and economic impacts. However, knowledge about consumer mobile phone (MP) recycling behaviour is fragmented, making it challenging to develop effective strategies to promote this behaviour. This study follows the Preferred
Xinru (Angie) Jiang, Ninh Nguyen, Steven Greenland, Jacqueline K. Eastman, Chrystie Watson   +4 more
wiley   +1 more source

Machine Learning-Based Pitting Rate Classification and Prediction for 316L Stainless Steel in NaClO₃ and NaCl Environment. [PDF]

Materials (Basel)
Zhang C, Yao J, Zhang Z.
europepmc   +1 more source

Biomarker‐Based Prediction of OATP1B1 Activity in Clinical Routine—Investigating Coproporphyrins as Markers for Drug–Drug–Gene Interactions

Clinical Pharmacology &Therapeutics, EarlyView.
Coproporphyrin I (CPI) is an established endogenous biomarker for detecting drug–drug interactions (DDIs) involving the hepatic uptake transporter Organic Anion Transporting Polypeptide 1B1 (OATP1B1, gene SLCO1B1). While CPI has been extensively studied in healthy volunteers using controlled pre‐ and post‐OATP1B1‐inhibitor sampling, its applicability ...
Leila Potzel, Anina Zumtaugwald, Anna Bollinger, Chiara Jeiziner, Kurt E. Hersberger, Florine Wiss, Markus L. Lampert, Samuel S. Allemann, Henriette E. Meyer zu Schwabedissen, Céline K. Stäuble   +9 more
wiley   +1 more source

Gastric-Type Mixed Neoplastic and Non-Neoplastic Lesions in the Duodenal Bulb: A Case Supporting the Metaplasia-Neoplasia Sequence. [PDF]

Diagnostics (Basel)
Satomi H, Uedo N, Ishiguro S, Kairiku Y, Michida T, Ishihara R, Honma K.   +6 more
europepmc   +1 more source

Digital Transformation of Medicines Regulation in Africa—Perspectives from a Stakeholder Convening

Clinical Pharmacology &Therapeutics, EarlyView.
Regulatory authorities worldwide are developing strategies to integrate artificial intelligence (AI) into the lifecycle of health products, technologies, and medicines. While regulators share goals of improving efficiency, strengthening decision‐making, and protecting public health, their approaches differ according to institutional structures ...
Christelna Reyneke, Boitumelo Semete‐Makokotlela, Varnika Singh, Khanyisile Nkuku, Madelein Terblanche, Ezekiel T Mukanga, Nancy Ngum, Kudakwashe Dandajena, McNeil Chimus Mhango, Paulyne Wairimu, John Mwangi, Dominique Lagrave, Goonaseelan (Colin) Pillai   +12 more
wiley   +1 more source

Correction: Azam et al. Removal of Chromium(III) and Cadmium(II) Heavy Metal Ions from Aqueous Solutions Using Treated Date Seeds: An Eco-Friendly Method. <i>Molecules</i> 2021, <i>26</i>, 3718. [PDF]

Molecules
Azam M, Wabaidur SM, Khan MR, Al-Resayes SI, Islam MS.   +4 more
europepmc   +1 more source

Patient‐Centric First‐in‐Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T‐Cell Engagers in Multiple Myeloma

Clinical Pharmacology &Therapeutics, EarlyView.
The minimal anticipated biological effect level (MABEL) approach to first‐in‐human (FIH) dose calculation can lead to long dose‐escalation periods before observing clinical activity. We used a novel ex vivo MABEL approach to calculate the FIH starting dose for forimtamig, a T‐cell bispecific antibody under investigation for the treatment of relapsed ...
Thomas E. Kraft, Estelle Marrer‐Berger, Sara Belli, Helene Haegel, Anneliese Schneider, Anna Maria Giusti, Michael Bscheider, Wolfgang Jacob, Martin Weisser, Laura Blanco, Nicolas Frances, Eva Rossmann, Guido Steiner, Aintzane Zabaleta Azpiroz, Bruno Paiva, Ludovic Martinet, Tanja Fauti   +16 more
wiley   +1 more source